If your child does develop cancer, it is important to know that it is extremely unlikely there is anything you or your child could have done to prevent it. Unlike many cancers of adults, there are no lifestyle-related risk factors (such as smoking) that are known to influence a child’s risk of getting cancer. Very few environmental factors, such as radiation exposure, have been linked with childhood cancer risk.
However, a child might inherit a genetic alteration that makes them very likely to get a certain kind of cancer. These are the patients with hereditary cancer predisposition syndromes. In such cases, our primarily objective is to improve the chances of long-term survival by early detection of likely childhood cancers. This is done by implementation of cancer surveillance protocols consisting of appropriate imaging and testing for known biomarkers along with comprehensive interpretation of results and treatment strategies in a multidisciplinary approach.
In many cases exposure to radiation/chemotherapy may be unavoidable, such as if the child needs radiation therapy to treat another cancer. Children, who are long-term survivors of childhood cancers, are also seen in this clinic. Our primary objective for these patients is to monitor and prevent late effects of cancer treatment, namely endocrine issues (diabetes, hypothyroidism, growth failure, infertility), decreased bone density and avascular necrosis along with monitoring and early detection of potential disease relapse or development of other cancers. We want to see these long-term survivors of childhood cancer be productive part of the society and continue to lead normal lives.
Rishi Chavan MD
Dr. Chavan joined the section of pediatric hematology/oncology as an attending physician in 2012 after completing fellowship training in pediatric hematology oncology Texas Children’s Cancer and Hematology Centers – Baylor College of Medicine in Houston. Prior to which he was here at Tulane for his pediatric residency from 2006 to 2009 working with Drs. Scher, Hemenway and Schorin.
Dr. Chavan is currently implementing clinical trials and surveillance protocols for patients with hereditary cancer predisposition syndromes, for which he is closely working with Dr Hans Anderson and Dr Eva Morava in the Hayward Genetics Center.
He is also leading the efforts in comprehensive follow up of long-term survivors of childhood cancer aspiring to improve their quality of life in efforts to monitor and prevent late–effects of cancer treatments, chemotherapy and radiation.
Senior Program Manager
Lisa was raised in New Orleans and received her undergraduate degree from LSU in Baton Rouge. After working in industry for 12 years, she returned to school and received a graduate degree in the biomedical field from Tulane University. Lisa began her clinical research career in 1995 as a Clinical Research Coordinator in the section of Pediatric Hematology/Oncology. Since that time, she has initiated, coordinated and maintained all Children’s Oncology Group protocols; there are currently 65 open protocols. Additionally she has maintained industry sponsored clinical trials involving pain management in pediatric cancer patients, therapies for pediatric thrombosis, and investigational drugs used to treat leukemias and lymphomas. Lisa has also served as a member of the Tulane University Biomedical Institutional Review Board (IRB) since 2010. Her goal is to contribute to the advancement of the treatment of childhood and adolescent cancer.
Lauren is a first-year Medical Student at Tulane through Tulane’s Accelerated Physician Training Program (TAP-TP). Through the program, she completed her undergraduate studies in two years and served one year with AmeriCorps at a local non-profit, Youth Rebuilding New Orleans. Lauren is an aspiring pediatrician is passionate about pediatric patient care.
Whom to refer
For the late-effects monitoring we are seeing all the long-term survivors of childhood cancer who are three years away from their last chemotherapy.
Below is the list of most common hereditary cancer predisposition syndromes:
Neurofibromatosis Bone marrow failure syndromes
Familial Adenomatous Polyposis
PTEN hamartoma syndromes (e.g. Cowden Syndrome)
Li-Fraumeni Syndrome Hereditary
Rhabdoid Predisposition Syndrome
Biallelic Mismatch Repair Gene Mutations
Phone: 504 342 0254 Fax: 504 988 8691
Tulane University Hospital and Clinic
5th floor Pediatric Clinic
1415 Tulane Ave, New Orleans LA 70112
1430 Tulane Ave, New Orleans, LA 70112 504-988-5187 firstname.lastname@example.org